How can you say the results are modest when patients treated with a drug intended to prevent a rise in cytokines, showed complete absence of a rise in cytokines?? How could the results have been better?
What am I missing?
(And saying "probably the same level of expertise you bring to the table" is not an answer. It wasn't a loaded question, why not answer it? Your statement "I’m unconvinced it’ll do anything in Covid or septic shock" calls for either a discussion of the data or a statement of your expertise.)
Ann: Veyonda FDA Approved Trial to Commence, page-31
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $33.60M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 33616 | 1 |
View Market Depth
| Last trade - 16.12pm 08/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable